In our study, CDD effectively improved body weight, insulin resistance index, and ovarian function in PCOS-IR model mice, and significantly downregulated both mRNA and protein expression levels of the IL6/JAK2/STAT3/FOXO4 signaling pathway. Here, JAK2 is linked to craniodiaphyseal dysplasia.